Back
Larimar Therapeutics Vs. Design Therapeutics Industry Stock Comparison
Sell
38
LRMR
Larimar Therapeutics
Last Price:
6.85
Seasonality Move:
-2.11%
Buy
52
DSGN
Design Therapeutics
Last Price:
5.64
Seasonality Move:
-24.36%
Sell
38
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $6.81. The Score for LRMR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LRMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $5.77. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $6.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $5.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight buying pressure.
LRMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 40.45 | Sell |
| Chaikin Money Flow: | 302776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.24 - 8.16) | Sell |
| Bollinger Bands (100): | (7.13 - 9.09) | Sell |
DSGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 62.68 | Buy |
| Chaikin Money Flow: | 20818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 5.4) | Buy |
| Bollinger Bands (100): | (3.66 - 4.92) | Buy |
LRMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.36 | Sell |
| 20-day SMA: | 7.7 | Sell |
| 50-day SMA: | 8.31 | Sell |
| 200-day SMA: | 7.48 | Sell |
| 8-day EMA: | 7.25 | Sell |
| 20-day EMA: | 7.59 | Sell |
| 50-day EMA: | 7.92 | Sell |
| 200-day EMA: | 7.32 | Sell |
DSGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.39 | Buy |
| 20-day SMA: | 5.09 | Buy |
| 50-day SMA: | 4.7 | Buy |
| 200-day SMA: | 3.57 | Buy |
| 8-day EMA: | 5.44 | Buy |
| 20-day EMA: | 5.12 | Buy |
| 50-day EMA: | 4.73 | Buy |
| 200-day EMA: | 4.18 | Buy |
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Larimar Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Design Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||